NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
11/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
224 |
08/13/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
34 |
05/14/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
32 |
11/13/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
97 |
08/10/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
95 |
05/22/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
35 |
05/16/23 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
![]() |
2 | |
11/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
39 |
08/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
40 |
05/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
56 |